Radiology Coding Alert

ICD-10:

198.5 Splits to Distinct Bone/Bone Marrow Options for ICD-10

Be sure documentation clearly helps you choose between C79.51 and C79.52.If your practice provides imaging of bone metastases, take note: ICD-10 will double your coding options.ICD-9: Under ICD-9 2011, you report 198.5 (Secondary malignant neoplasm of other specified sites; bone and bone marrow) to indicate the confirmed presence of cancer that has spread from a different (primary) site to the bones or bone marrow.ICD-10: The new codeset, planned to take effect Oct. 1, 2013, will offer two distinct codes for this diagnosis:C79.51, Secondary malignant neoplasm of bone C79.52, Secondary malignant neoplasm of bone marrow.Documentation: The switch to two separate codes means that clear confirmation of whether the bone or bone marrow is involved will be crucial to your ability to choose the proper code.Coder tip: Both ICD-9 and ICD-10 provide alternate codes for secondary neuroendocrine tumors. Under ICD-9, you use 209.73 (Secondary neuroendocrine tumor of bone). ICD-10 includes C7B.03 (Secondary [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Radiology Coding Alert

View All